Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Bayer Schering Pharma presents new MEK/ERK inhibitors

May 16, 2011

Boehringer Ingelheim patents new chemokine CCR1 receptor antagonists

May 16, 2011

Merck KGaA designs new PI3K inhibitors

May 13, 2011

New fatty acid synthase inhibitors prepared

May 13, 2011

Fibrotech Therapeutics presents novel antifibrotic compounds

May 13, 2011

Novartis patents new sodium/glucose cotransporter inhibitors

May 13, 2011

Novel MEK/ERK inhibitors disclosed by Bayer Schering Pharma

May 13, 2011

Myrexis divulges new inhibitors of TBK1 and/or IKK-epsilon

May 13, 2011

Duquesne University presents new tamoxifen-melatonin hybrid ligand

May 12, 2011

New calcitonin CGRP receptor antagonists disclosed

May 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...